Edouard Dahl
Director/Board Member at DEVONIAN HEALTH GROUP INC.
Net worth: - $ as of 29/04/2024
Profile
Edouard Dahl is an Independent Director at Devonian Health Group, Inc. since 2023.
He was previously a Director of Mergers & Acquisitions at Sanofi Canada, Inc. He obtained his undergraduate degree from Concordia University in 1979.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/05/2023 | 0 ( -.--% ) | - $ | 29/04/2024 |
Edouard Dahl active positions
| Companies | Position | Start |
|---|---|---|
| DEVONIAN HEALTH GROUP INC. | Director/Board Member | 11/05/2023 |
Former positions of Edouard Dahl
| Companies | Position | End |
|---|---|---|
Sanofi Canada, Inc.
 Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Corporate Officer/Principal | 23/03/2023 |
Training of Edouard Dahl
| Concordia University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DEVONIAN HEALTH GROUP INC. | Health Technology |
| Private companies | 1 |
|---|---|
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Health Technology |
- Stock Market
- Insiders
- Edouard Dahl
